BioSpace News Archive

FDA

FDA Approves Ultragenyx’s Treatment for Rare Genetic Enzyme Disorder

The FDA today approved Mepsevii to treat pediatric and adult patients with an inherited metabolic condition called MPS VII, also known as Sly syndrome.

November 15, 2017
·
3 min read
Business

Tempus Announces Latest Immunotherapy Project

The company announced a new research collaboration aimed at identifying which patients will respond positively to immunotherapy treatment, the next generation of cancer care.

November 15, 2017
·
4 min read
Business

Novartis, ASCP and ACS Join Forces to Fight Cancer in Ethiopia, Uganda and Tanzania

November 15, 2017
·
7 min read
Drug Development

HEALIOS Announces Enrollment of First Patient in Japan in TREASURE Study of MultiStem Treatment for Ischemic Stroke

Off-the-shelf stem cell therapy has potential to extend treatment window and enhance recovery for stroke patients.

November 15, 2017
·
10 min read
Business

Hemispherx Biopharma Announces Corporate Progress and Financial Results for the Nine Months Ended September 30, 2017

The net loss was $1.3 million for the three months ended September 2017 compared to $2.9 million in this period one year ago.

November 15, 2017
·
2 min read
Pharm Country

Motif Bio Secures Up to $20M Debt Financing

The funds will be used to fund pre-commercialisation activities and other corporate activities in preparation for the anticipated US launch of iclaprim in 2019.

November 15, 2017
·
6 min read
Drug Development

Significant Improvements Reported in Duchenne Muscular Dystrophy Patients Treated With Capricor’s Investigational Cell Therapy

These findings were reported today by Ronald G. Victor, M.D. at a Late-Breaking Science session of the American Heart Association Scientific Sessions 2017.

November 15, 2017
·
9 min read
Biotech Bay

CSSi LifeSciences Release: Jim Sergi Invited to Serve as Moderator for 2017 World Alliance Forum in San Francisco

Mr. Sergi will moderate the panel discussion titled, “Cancer Moonshot.”

November 15, 2017
·
2 min read
BioCapital

FDA unveils a streamlined path for the authorization of tumor profiling tests alongside its latest product action

The IMPACT test uses NGS to rapidly identify the presence of mutations in 468 unique genes, as well as other molecular changes in the genomic makeup of a person’s tumor.

November 15, 2017
·
5 min read
Business

Scott VanderWel Joins PCI Synthesis as Business Development Manager

VanderWel will lead sales and marketing efforts for the West Coast.

November 15, 2017
·
2 min read